1,980
Views
29
CrossRef citations to date
0
Altmetric
Research article

Dendritic cells release exosomes together with phagocytosed pathogen; potential implications for the role of exosomes in antigen presentation

, , , , & ORCID Icon
Article: 1798606 | Received 23 Jan 2020, Accepted 29 Jun 2020, Published online: 26 Jul 2020

References

  • Savina A, Amigorena S. Phagocytosis and antigen presentation in dendritic cells. Immunol Rev. 2007;219:143–14.
  • Zitvogel L, Regnault A, Lozier A, et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med. 1998;4:594–600.
  • Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009;9:581–593.
  • Lindenbergh MFS, Stoorvogel W. Antigen presentation by extracellular vesicles from professional antigen-presenting cells. Annu Rev Immunol. 2018;36:435–459.
  • Théry C, Duban L, Segura E, et al. Indirect activation of naïve CD4+T cells by dendritic cell-derived exosomes. Nat Immunol. 2002;3:1156–1162.
  • Andre F, Chaput N, Schartz NEC, et al. Exosomes as potent cell-free peptide-based vaccine. I. dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J Immunol. 2004;172:2126–2136.
  • Naslund TI, Gehrmann U, Qazi KR, et al. Dendritic cell-derived exosomes need to activate both T- and B-cells to induce antitumor immunity. J Immunol. 2013;190:2712–2719.
  • Tkach M, Kowal J, Théry C. Why the need and how to approach the functional diversity of extracellular vesicles. Philos Trans R Soc B Biol Sci. 2018 Jan 5;373(1737):20160479.
  • Wahlund CJE, Güclüler G, Hiltbrunner S, et al. Exosomes from antigen-pulsed dendritic cells induce stronger antigen-specific immune responses than microvesicles in vivo. Sci Rep. 2017;7:1–9.
  • Tkach M, Kowal J, Zucchetti AE, et al. Qualitative differences in T‐cell activation by dendritic cell‐derived extracellular vesicle subtypes. Embo J. 2017;36:3012–3028.
  • Segura E, Amigorena S, Théry C. Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses. Blood Cells Mol Dis. 2005;35:89–93.
  • Kowal J, Arras G, Colombo M, et al. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci. 2016;113:E968–E977.
  • Damo M, Wilson DS, Simeoni E, et al. TLR-3 stimulation improves anti-tumor immunity elicited by dendritic cell exosome-based vaccines in a murine model of melanoma. Sci Rep. 2015;5:1–15.
  • Aline F, Bout D, Amigorena S, et al. Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T. gondii Infection. Infect Immun. 2004;72:4127–4137.
  • Beauvillain C, Ruiz S, Guiton R, et al. A vaccine based on exosomes secreted by a dendritic cell line confers protection against T. gondii infection in syngeneic and allogeneic mice. Microbes Infect. 2007;9:1614–1622.
  • Buschow SI, Nolte-‘t Hoen ENM, van Niel G, et al. MHC II In dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways. Traffic. 2009;10:1528–1542.
  • Lindenbergh MFS, Koerhuis DGJ, Borg EGF. Bystander T-cells support clonal T-cell activation by controlling the release of dendritic cell-derived immune-stimulatory extracellular vesicles. Front Immunol. 2019;10:1–11.
  • Hu G, Gong A-Y, Roth AL, et al. Release of luminal exosomes contributes to TLR4-mediated epithelial antimicrobial defense. PLoS Pathog. 2013;9:e1003261.
  • Qu C, Nguyen VA, Merad M, et al. MHC class I/peptide transfer between dendritic cells overcomes poor cross-presentation by monocyte-derived APCs that engulf dying cells. J Immunol. 2009;182:3650–3659.
  • Ramachandra L, Qu Y, Wang Y, et al. Mycobacterium tuberculosis synergizes with ATP to induce release of microvesicles and exosomes containing major histocompatibility complex class II molecules capable of antigen presentation. Infect Immun. 2010;78:5116–5125.
  • Alvarez M, Casadevall A. Phagosome extrusion and host-cell survival after cryptococcus neoformans phagocytosis by macrophages. Curr Biol. 2006;16:2161–2165.
  • Ma H, Croudace JE, Lammas DA, et al. Expulsion of live pathogenic yeast by macrophages. Curr Biol. 2006;16:2156–2160.
  • Bain JM, Lewis LE, Okai B, et al. Non-lytic expulsion/exocytosis of Candida albicans from macrophages. Fungal Genet Biol. 2012;49:677–678.
  • Johnston SA, May RC. The human fungal pathogen Cryptococcus neoformans escapes macrophages by a phagosome emptying mechanism that is inhibited by arp2/3 complex- mediated actin polymerisation. PLoS Pathog. 2010;6:27–28.
  • Miao Y, Li G, Zhang X, et al. A TRP channel senses lysosome neutralization by pathogens to trigger their expulsion. Cell. 2015;161:1306–1319.
  • Sallusto BF, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus iuterleukin 4 and downregulated by tumor necrosis factor a. J Exp Med. 1994;179:1109–1118.
  • Raposo G, Nijman HW, Stoorvogel W. B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 1996;183:1161–1172.
  • Latysheva N, Muratov G, Rajesh S, et al. Syntenin-1 is a new component of tetraspanin-enriched microdomains: mechanisms and consequences of the interaction of syntenin-1 with CD63. Mol Cell Biol. 2006;26:7707–7718.
  • Hurwitz SN, Nkosi D, Conlon MM, et al. CD63 regulates epstein-barr virus LMP1 exosomal packaging, enhancement of vesicle production, and noncanonical NF-kB signaling. J Virol. 2017;91:1–19.
  • Théry C, Regnault A, Garin J, et al. Molecular characterization of dendritic cell-derived exosomes: selective accumulation of the heat shock protein hsc73. J Cell Biol. 1999;147:599–610.
  • Nolte-’t Hoen ENM, Buschow SI, Anderton SM, et al. Activated T cells recruit exosomes secreted by dendritic cells via LFA-1. Blood. 2009;113:1977–1981.
  • Verweij FJ, Bebelman MP, Jimenez CR, et al. Quantifying exosome secretion from single cells reveals a modulatory role for GPCR signaling. J Cell Biol. 2018;217:1129–1142.
  • Savina A, Jancic C, Hugues S, et al. NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell. 2006;126:205–218.
  • Alloatti A, Kotsias F, Pauwels A-M, et al. Toll-like receptor 4 engagement on dendritic cells restrains phago-lysosome fusion and promotes cross-presentation of antigens. Immunity. 2015;43:1087–1100.
  • Rescigno M, Urbano M, Valzasina B, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol. 2001;2:361–367.
  • Miao Y, Wu J, Abraham SN. Ubiquitination of Innate immune regulator TRAF3 orchestrates expulsion of intracellular bacteria by exocyst complex. Immunity. 2016;45:94–105.
  • Morelli AE, Larregina AT, Shufesky WJ, et al. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood. 2004;104:3257–3266.
  • Smith VL, Cheng Y, Bryant BR, et al. Exosomes function in antigen presentation during an in vivo Mycobacterium tuberculosis infection. Sci Rep. 2017;7:1–12.
  • Rodriguez A, Vigorito E, Clare S, et al. Requirement of bic/microRNA-155 for normal immune function. Science. 2007;981:608–611.
  • Caron E, Kowalewski DJ, Chiek Koh C, et al. Analysis of Major Histocompatibility Complex (MHC) immunopeptidomes using mass spectrometry. Mol Cell Proteomics. 2015;14:3105–3117.
  • Mommen GPM, Marino F, Meiring HD, et al. Sampling from the proteome to the human leukocyte antigen-DR (HLA-DR) ligandome proceeds via high specificity. Mol Cell Proteomics. 2016;15:1412–1423.
  • Edgar JR, Manna PT, Nishimura S, et al. Tetherin is an exosomal tether. Elife. 2016;5:1–19.
  • Segura E, Guerin C, Hogg N, et al. CD8+ dendritic cells use LFA-1 to capture MHC-peptide complexes from exosomes in vivo. J Immunol. 2007;179:1489–1496.
  • Bachmann MF, Ohashi PS. The role of T-cell receptor dimerization in T-cell activation. Immunol Today. 1999;20:568–575.
  • Brown JH, Jardetzky TS, Gorga JC, et al. Three-dimensional structure of the human class II histocompatibility antigen LA-DR1. Nature. 1993;364:33–39.
  • Schafer PH, Pierce SK. Evidence for dimers of MHC class II molecules in B lymphocytes and their role in low affinity T cell responses. Immunity. 1994;1:699–707.
  • Harding CV, Unanue ER. Quantitation of antigen- presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature. 1990;346:574–576.